Convalescent plasma treatment of severe COVID-19: a propensity score-matched control study

Journal Title:	Nature medicine 2020-11, Vol.26 (11), p.1708-1713
Main Author:	Liu, Sean T H
Other Authors:	Lin, Hung-Mo , Baine, Ian , Wajnberg, Ania , Gumprecht, Jeffrey P , Rahman, Farah , Rodriguez, Denise , Tandon, Pranai , Bassily-Marcus, Adel , Bander, Jeffrey , Sanky, Charles , Dupper, Amy , Zheng, Allen , Nguyen, Freddy T , Amanat, Fatima , Stadlbauer, Daniel , Altman, Deena R , Chen, Benjamin K , Krammer, Florian , Mendu, Damodara Rao , Firpo-Betancourt, Adolfo , Levin, Matthew A , Bagiella, Emilia , Casadevall, Arturo , Cordon-Cardo, Carlos , Jhang, Jeffrey S , Arinsburg, Suzanne A , Reich, David L , Aberg, Judith A , Bouvier, Nicole M
Format:	Electronic Article
Language:	English
Subjects:	Adult Aged Antibodies Antibodies, Viral - blood Case-Control Studies Chi-square test Clinical trials Confidence intervals Coronaviruses COVID-19 COVID-19 - epidemiology COVID-19 - pathology COVID-19 - therapy Disease control Female Health services Humans Immunization, Passive Infectious diseases Male Medical treatment Middle Aged Oxygen requirement Pandemics Patients Plasma Propensity Score Public health Respiratory diseases Retrospective Studies SARS-CoV-2 - immunology Severe acute respiratory syndrome Severe acute respiratory syndrome coronavirus 2 Severity of Illness Index Statistical tests Survival Transfusion Treatment Outcome Vaccines Viral diseases Viruses
Publisher:	United States: Nature Publishing Group
ID:	ISSN: 1078-8956
Link:	https://www.ncbi.nlm.nih.gov/pubmed/32934372
Zum Text:

Staff View

recordid:	cdi_proquest_miscellaneous_2443521242
title:	Convalescent plasma treatment of severe COVID-19: a propensity score-matched control study
format:	Article
creator:	Liu, Sean T H Lin, Hung-Mo Baine, Ian Wajnberg, Ania Gumprecht, Jeffrey P Rahman, Farah Rodriguez, Denise Tandon, Pranai Bassily-Marcus, Adel Bander, Jeffrey Sanky, Charles Dupper, Amy Zheng, Allen Nguyen, Freddy T Amanat, Fatima Stadlbauer, Daniel Altman, Deena R Chen, Benjamin K Krammer, Florian Mendu, Damodara Rao Firpo-Betancourt, Adolfo Levin, Matthew A Bagiella, Emilia Casadevall, Arturo Cordon-Cardo, Carlos Jhang, Jeffrey S Arinsburg, Suzanne A Reich, David L Aberg, Judith A Bouvier, Nicole M
subjects:	Adult Aged Antibodies Antibodies, Viral - blood Case-Control Studies Chi-square test Clinical trials Confidence intervals Coronaviruses COVID-19 COVID-19 - epidemiology COVID-19 - pathology COVID-19 - therapy Disease control Female Health services Humans Immunization, Passive Infectious diseases Male Medical treatment Middle Aged Oxygen requirement Pandemics Patients Plasma Propensity Score Public health Respiratory diseases Retrospective Studies SARS-CoV-2 - immunology Severe acute respiratory syndrome Severe acute respiratory syndrome coronavirus 2 Severity of Illness Index Statistical tests Survival Transfusion Treatment Outcome Vaccines Viral diseases Viruses
ispartof:	Nature medicine, 2020-11, Vol.26 (11), p.1708-1713
description:	Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a new human disease with few effective treatments . Convalescent plasma, donated by persons who have recovered from COVID-19, is the acellular component of blood that contains antibodies, including those that specifically recognize SARS-CoV-2. These antibodies, when transfused into patients infected with SARS-CoV-2, are thought to exert an antiviral effect, suppressing virus replication before patients have mounted their own humoral immune responses . Virus-specific antibodies from recovered persons are often the first available therapy for an emerging infectious disease, a stopgap treatment while new antivirals and vaccines are being developed . This retrospective, propensity score-matched case-control study assessed the effectiveness of convalescent plasma therapy in 39 patients with severe or life-threatening COVID-19 at The Mount Sinai Hospital in New York City. Oxygen requirements on day 14 after transfusion worsened in 17.9% of plasma recipients versus 28.2% of propensity score-matched controls who were hospitalized with COVID-19 (adjusted odds ratio (OR), 0.86; 95% confidence interval (CI), 0.75-0.98; chi-square test P value = 0.025). Survival also improved in plasma recipients (adjusted hazard ratio (HR), 0.34; 95% CI, 0.13-0.89; chi-square test P = 0.027). Convalescent plasma is potentially effective against COVID-19, but adequately powered, randomized controlled trials are needed.
language:	eng
source:
identifier:	ISSN: 1078-8956
fulltext:	no_fulltext
issn:	1078-8956 1546-170X
url:	Link

@attributes

NO	1
SEARCH_ENGINE	primo_central_multiple_fe
SEARCH_ENGINE_TYPE	Primo Central Search Engine
RANK	2.8895378
LOCAL	false

PrimoNMBib

record

control

sourceid	gale_proqu
recordid	TN_cdi_proquest_miscellaneous_2443521242
sourceformat	XML
sourcesystem	PC
galeid	A650810393
sourcerecordid	A650810393
originalsourceid	FETCH-LOGICAL-c462t-5bf88a9298237d9032af8d7a69455ba5be4e531d1a6111a6e7133290f3f804ba0
addsrcrecordid	eNp9ku1r1TAUxosobk7_AL9IQRD3ITOvbeK3cdV5YXDBlyF-CWl7stvRNjVJh_e_N-Xqto4hgSQcfufhnIcny14SfEIwk-8CJ0IRhClGBEuJ1KPskAheIFLiH4_TH5cSSSWKg-xZCFcYY4aFepodMKoYZyU9zH6u3HBtOgg1DDEfOxN6k0cPJvZzwdk8wDV4yFebi_UHRNT73OSjdyMMoY27PNTOA-pNrLfQ5LUbonddHuLU7J5nT6zpArz4-x5l3z99_Lb6jM43Z-vV6TmqeUEjEpWV0iiqJGVlozCjxsqmNIXiQlRGVMBBMNIQUxCSLigJS_Njy6zEvDL4KHu7101j_ZogRN23aZ2uMwO4KWjKOROUUE4T-voeeuUmP6TpElWyGSLilrpMxuh2sC56U8-i-rQQWCbvFUvUyQNUOg30bTICbJvqi4ZXDzTou8DxApjdhN_x0kwh6PXXL0ux_7GbiyX75g67BdPFbXDdFFs3hCVI9mDtXQgerB592xu_0wTrOXF6nzidEqfnxGl1u9U4VT00Nx3_Iob_AFj2yW8
sourcetype	Aggregation Database
isCDI	true
recordtype	article
pqid	2473212415

display

type

article

title

Convalescent plasma treatment of severe COVID-19: a propensity score-matched control study

creator

Liu, Sean T H ; Lin, Hung-Mo ; Baine, Ian ; Wajnberg, Ania ; Gumprecht, Jeffrey P ; Rahman, Farah ; Rodriguez, Denise ; Tandon, Pranai ; Bassily-Marcus, Adel ; Bander, Jeffrey ; Sanky, Charles ; Dupper, Amy ; Zheng, Allen ; Nguyen, Freddy T ; Amanat, Fatima ; Stadlbauer, Daniel ; Altman, Deena R ; Chen, Benjamin K ; Krammer, Florian ; Mendu, Damodara Rao ; Firpo-Betancourt, Adolfo ; Levin, Matthew A ; Bagiella, Emilia ; Casadevall, Arturo ; Cordon-Cardo, Carlos ; Jhang, Jeffrey S ; Arinsburg, Suzanne A ; Reich, David L ; Aberg, Judith A ; Bouvier, Nicole M

creatorcontrib

description

Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a new human disease with few effective treatments . Convalescent plasma, donated by persons who have recovered from COVID-19, is the acellular component of blood that contains antibodies, including those that specifically recognize SARS-CoV-2. These antibodies, when transfused into patients infected with SARS-CoV-2, are thought to exert an antiviral effect, suppressing virus replication before patients have mounted their own humoral immune responses . Virus-specific antibodies from recovered persons are often the first available therapy for an emerging infectious disease, a stopgap treatment while new antivirals and vaccines are being developed . This retrospective, propensity score-matched case-control study assessed the effectiveness of convalescent plasma therapy in 39 patients with severe or life-threatening COVID-19 at The Mount Sinai Hospital in New York City. Oxygen requirements on day 14 after transfusion worsened in 17.9% of plasma recipients versus 28.2% of propensity score-matched controls who were hospitalized with COVID-19 (adjusted odds ratio (OR), 0.86; 95% confidence interval (CI), 0.75-0.98; chi-square test P value = 0.025). Survival also improved in plasma recipients (adjusted hazard ratio (HR), 0.34; 95% CI, 0.13-0.89; chi-square test P = 0.027). Convalescent plasma is potentially effective against COVID-19, but adequately powered, randomized controlled trials are needed.

identifier

0	ISSN: 1078-8956
1	EISSN: 1546-170X
2	DOI: 10.1038/s41591-020-1088-9
3	PMID: 32934372

language

eng

publisher

United States: Nature Publishing Group

subject

Adult ; Aged ; Antibodies ; Antibodies, Viral - blood ; Case-Control Studies ; Chi-square test ; Clinical trials ; Confidence intervals ; Coronaviruses ; COVID-19 ; COVID-19 - epidemiology ; COVID-19 - pathology ; COVID-19 - therapy ; Disease control ; Female ; Health services ; Humans ; Immunization, Passive ; Infectious diseases ; Male ; Medical treatment ; Middle Aged ; Oxygen requirement ; Pandemics ; Patients ; Plasma ; Propensity Score ; Public health ; Respiratory diseases ; Retrospective Studies ; SARS-CoV-2 - immunology ; Severe acute respiratory syndrome ; Severe acute respiratory syndrome coronavirus 2 ; Severity of Illness Index ; Statistical tests ; Survival ; Transfusion ; Treatment Outcome ; Vaccines ; Viral diseases ; Viruses

ispartof

Nature medicine, 2020-11, Vol.26 (11), p.1708-1713

rights

The Author(s), under exclusive licence to Springer Nature America, Inc. 2020.

lds50

peer_reviewed

free_for_read

cites

FETCH-LOGICAL-c462t-5bf88a9298237d9032af8d7a69455ba5be4e531d1a6111a6e7133290f3f804ba0

orcidid

0000-0001-8162-0284 ; 0000-0002-4530-2841 ; 0000-0003-4121-776X ; 0000-0001-6792-7650 ; 0000-0003-1948-3834 ; 0000-0002-6013-2684 ; 0000-0002-3842-6838 ; 0000-0003-0106-8114 ; 0000-0003-1103-839X

links

openurl	$$Topenurl_article
thumbnail	$$Usyndetics_thumb_exl
backlink	$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32934372$$D View this record in MEDLINE/PubMed

search

creatorcontrib

0	Liu, Sean T H
1	Lin, Hung-Mo
2	Baine, Ian
3	Wajnberg, Ania
4	Gumprecht, Jeffrey P
5	Rahman, Farah
6	Rodriguez, Denise
7	Tandon, Pranai
8	Bassily-Marcus, Adel
9	Bander, Jeffrey
10	Sanky, Charles
11	Dupper, Amy
12	Zheng, Allen
13	Nguyen, Freddy T
14	Amanat, Fatima
15	Stadlbauer, Daniel
16	Altman, Deena R
17	Chen, Benjamin K
18	Krammer, Florian
19	Mendu, Damodara Rao
20	Firpo-Betancourt, Adolfo
21	Levin, Matthew A
22	Bagiella, Emilia
23	Casadevall, Arturo
24	Cordon-Cardo, Carlos
25	Jhang, Jeffrey S
26	Arinsburg, Suzanne A
27	Reich, David L
28	Aberg, Judith A
29	Bouvier, Nicole M

title

0	Convalescent plasma treatment of severe COVID-19: a propensity score-matched control study
1	Nature medicine

addtitle

Nat Med

description

subject

0	Adult
1	Aged
2	Antibodies
3	Antibodies, Viral - blood
4	Case-Control Studies
5	Chi-square test
6	Clinical trials
7	Confidence intervals
8	Coronaviruses
9	COVID-19
10	COVID-19 - epidemiology
11	COVID-19 - pathology
12	COVID-19 - therapy
13	Disease control
14	Female
15	Health services
16	Humans
17	Immunization, Passive
18	Infectious diseases
19	Male
20	Medical treatment
21	Middle Aged
22	Oxygen requirement
23	Pandemics
24	Patients
25	Plasma
26	Propensity Score
27	Public health
28	Respiratory diseases
29	Retrospective Studies
30	SARS-CoV-2 - immunology
31	Severe acute respiratory syndrome
32	Severe acute respiratory syndrome coronavirus 2
33	Severity of Illness Index
34	Statistical tests
35	Survival
36	Transfusion
37	Treatment Outcome
38	Vaccines
39	Viral diseases
40	Viruses

issn

0	1078-8956
1	1546-170X

fulltext

false

rsrctype

article

creationdate

2020

recordtype

article

recordid

eNp9ku1r1TAUxosobk7_AL9IQRD3ITOvbeK3cdV5YXDBlyF-CWl7stvRNjVJh_e_N-Xqto4hgSQcfufhnIcny14SfEIwk-8CJ0IRhClGBEuJ1KPskAheIFLiH4_TH5cSSSWKg-xZCFcYY4aFepodMKoYZyU9zH6u3HBtOgg1DDEfOxN6k0cPJvZzwdk8wDV4yFebi_UHRNT73OSjdyMMoY27PNTOA-pNrLfQ5LUbonddHuLU7J5nT6zpArz4-x5l3z99_Lb6jM43Z-vV6TmqeUEjEpWV0iiqJGVlozCjxsqmNIXiQlRGVMBBMNIQUxCSLigJS_Njy6zEvDL4KHu7101j_ZogRN23aZ2uMwO4KWjKOROUUE4T-voeeuUmP6TpElWyGSLilrpMxuh2sC56U8-i-rQQWCbvFUvUyQNUOg30bTICbJvqi4ZXDzTou8DxApjdhN_x0kwh6PXXL0ux_7GbiyX75g67BdPFbXDdFFs3hCVI9mDtXQgerB592xu_0wTrOXF6nzidEqfnxGl1u9U4VT00Nx3_Iob_AFj2yW8

startdate

202011

enddate

202011

creator

0	Liu, Sean T H
1	Lin, Hung-Mo
2	Baine, Ian
3	Wajnberg, Ania
4	Gumprecht, Jeffrey P
5	Rahman, Farah
6	Rodriguez, Denise
7	Tandon, Pranai
8	Bassily-Marcus, Adel
9	Bander, Jeffrey
10	Sanky, Charles
11	Dupper, Amy
12	Zheng, Allen
13	Nguyen, Freddy T
14	Amanat, Fatima
15	Stadlbauer, Daniel
16	Altman, Deena R
17	Chen, Benjamin K
18	Krammer, Florian
19	Mendu, Damodara Rao
20	Firpo-Betancourt, Adolfo
21	Levin, Matthew A
22	Bagiella, Emilia
23	Casadevall, Arturo
24	Cordon-Cardo, Carlos
25	Jhang, Jeffrey S
26	Arinsburg, Suzanne A
27	Reich, David L
28	Aberg, Judith A
29	Bouvier, Nicole M

general

Nature Publishing Group

scope

0	CGR
1	CUY
2	CVF
3	ECM
4	EIF
5	NPM
6	AAYXX
7	CITATION
8	BKMMT
9	BSHEE
10	3V.
11	7QG
12	7QL
13	7QP
14	7QR
15	7T5
16	7TK
17	7TM
18	7TO
19	7U7
20	7U9
21	7X7
22	7XB
23	88A
24	88E
25	88I
26	8AO
27	8FD
28	8FE
29	8FH
30	8FI
31	8FJ
32	8FK
33	8G5
34	ABUWG
35	AZQEC
36	BBNVY
37	BENPR
38	BHPHI
39	C1K
40	DWQXO
41	FR3
42	FYUFA
43	GHDGH
44	GNUQQ
45	GUQSH
46	H94
47	HCIFZ
48	K9.
49	LK8
50	M0S
51	M1P
52	M2O
53	M2P
54	M7N
55	M7P
56	MBDVC
57	P64
58	PADUT
59	PQEST
60	PQQKQ
61	PQUKI
62	PRINS
63	Q9U
64	RC3
65	7X8

orcidid

0	https://orcid.org/0000-0001-8162-0284
1	https://orcid.org/0000-0002-4530-2841
2	https://orcid.org/0000-0003-4121-776X
3	https://orcid.org/0000-0001-6792-7650
4	https://orcid.org/0000-0003-1948-3834
5	https://orcid.org/0000-0002-6013-2684
6	https://orcid.org/0000-0002-3842-6838
7	https://orcid.org/0000-0003-0106-8114
8	https://orcid.org/0000-0003-1103-839X

sort

creationdate	202011
title	Convalescent plasma treatment of severe COVID-19: a propensity score-matched control study
author	Liu, Sean T H ; Lin, Hung-Mo ; Baine, Ian ; Wajnberg, Ania ; Gumprecht, Jeffrey P ; Rahman, Farah ; Rodriguez, Denise ; Tandon, Pranai ; Bassily-Marcus, Adel ; Bander, Jeffrey ; Sanky, Charles ; Dupper, Amy ; Zheng, Allen ; Nguyen, Freddy T ; Amanat, Fatima ; Stadlbauer, Daniel ; Altman, Deena R ; Chen, Benjamin K ; Krammer, Florian ; Mendu, Damodara Rao ; Firpo-Betancourt, Adolfo ; Levin, Matthew A ; Bagiella, Emilia ; Casadevall, Arturo ; Cordon-Cardo, Carlos ; Jhang, Jeffrey S ; Arinsburg, Suzanne A ; Reich, David L ; Aberg, Judith A ; Bouvier, Nicole M

facets

frbrtype

frbrgroupid

cdi_FETCH-LOGICAL-c462t-5bf88a9298237d9032af8d7a69455ba5be4e531d1a6111a6e7133290f3f804ba0

rsrctype

articles

prefilter

articles

language

eng

creationdate

2020

topic

0	Adult
1	Aged
2	Antibodies
3	Antibodies, Viral - blood
4	Case-Control Studies
5	Chi-square test
6	Clinical trials
7	Confidence intervals
8	Coronaviruses
9	COVID-19
10	COVID-19 - epidemiology
11	COVID-19 - pathology
12	COVID-19 - therapy
13	Disease control
14	Female
15	Health services
16	Humans
17	Immunization, Passive
18	Infectious diseases
19	Male
20	Medical treatment
21	Middle Aged
22	Oxygen requirement
23	Pandemics
24	Patients
25	Plasma
26	Propensity Score
27	Public health
28	Respiratory diseases
29	Retrospective Studies
30	SARS-CoV-2 - immunology
31	Severe acute respiratory syndrome
32	Severe acute respiratory syndrome coronavirus 2
33	Severity of Illness Index
34	Statistical tests
35	Survival
36	Transfusion
37	Treatment Outcome
38	Vaccines
39	Viral diseases
40	Viruses

toplevel

peer_reviewed

creatorcontrib

0	Liu, Sean T H
1	Lin, Hung-Mo
2	Baine, Ian
3	Wajnberg, Ania
4	Gumprecht, Jeffrey P
5	Rahman, Farah
6	Rodriguez, Denise
7	Tandon, Pranai
8	Bassily-Marcus, Adel
9	Bander, Jeffrey
10	Sanky, Charles
11	Dupper, Amy
12	Zheng, Allen
13	Nguyen, Freddy T
14	Amanat, Fatima
15	Stadlbauer, Daniel
16	Altman, Deena R
17	Chen, Benjamin K
18	Krammer, Florian
19	Mendu, Damodara Rao
20	Firpo-Betancourt, Adolfo
21	Levin, Matthew A
22	Bagiella, Emilia
23	Casadevall, Arturo
24	Cordon-Cardo, Carlos
25	Jhang, Jeffrey S
26	Arinsburg, Suzanne A
27	Reich, David L
28	Aberg, Judith A
29	Bouvier, Nicole M

collection

0	Medline
1	MEDLINE
2	MEDLINE (Ovid)
3	MEDLINE
4	MEDLINE
5	PubMed
6	CrossRef
7	Gale General OneFile (A&I only)
8	Academic OneFile (A&I only)
9	ProQuest Central (Corporate)
10	Animal Behavior Abstracts
11	Bacteriology Abstracts (Microbiology B)
12	Calcium & Calcified Tissue Abstracts
13	Chemoreception Abstracts
14	Immunology Abstracts
15	Neurosciences Abstracts
16	Nucleic Acids Abstracts
17	Oncogenes and Growth Factors Abstracts
18	Toxicology Abstracts
19	Virology and AIDS Abstracts
20	Health & Medical Collection
21	ProQuest Central (purchase pre-March 2016)
22	Biology Database (Alumni Edition)
23	Medical Database (Alumni Edition)
24	Science Database (Alumni Edition)
25	ProQuest Pharma Collection
26	Technology Research Database
27	ProQuest SciTech Collection
28	ProQuest Natural Science Collection
29	Hospital Premium Collection
30	Hospital Premium Collection (Alumni Edition)
31	ProQuest Central (Alumni) (purchase pre-March 2016)
32	Research Library (Alumni Edition)
33	ProQuest Central (Alumni Edition)
34	ProQuest Central Essentials
35	Biological Science Collection
36	ProQuest Central
37	Natural Science Collection
38	Environmental Sciences and Pollution Management
39	ProQuest Central Korea
40	Engineering Research Database
41	Health Research Premium Collection
42	Health Research Premium Collection (Alumni)
43	ProQuest Central Student
44	Research Library Prep
45	AIDS and Cancer Research Abstracts
46	SciTech Premium Collection
47	ProQuest Health & Medical Complete (Alumni)
48	ProQuest Biological Science Collection
49	Health & Medical Collection (Alumni Edition)
50	Medical Database
51	Research Library
52	Science Database
53	Algology Mycology and Protozoology Abstracts (Microbiology C)
54	Biological Science Database
55	Research Library (Corporate)
56	Biotechnology and BioEngineering Abstracts
57	Research Library China
58	ProQuest One Academic Eastern Edition
59	ProQuest One Academic
60	ProQuest One Academic UKI Edition
61	ProQuest Central China
62	ProQuest Central Basic
63	Genetics Abstracts
64	MEDLINE - Academic

jtitle

Nature medicine

delivery

delcategory	Remote Search Resource
fulltext	no_fulltext

addata

0	Liu, Sean T H
1	Lin, Hung-Mo
2	Baine, Ian
3	Wajnberg, Ania
4	Gumprecht, Jeffrey P
5	Rahman, Farah
6	Rodriguez, Denise
7	Tandon, Pranai
8	Bassily-Marcus, Adel
9	Bander, Jeffrey
10	Sanky, Charles
11	Dupper, Amy
12	Zheng, Allen
13	Nguyen, Freddy T
14	Amanat, Fatima
15	Stadlbauer, Daniel
16	Altman, Deena R
17	Chen, Benjamin K
18	Krammer, Florian
19	Mendu, Damodara Rao
20	Firpo-Betancourt, Adolfo
21	Levin, Matthew A
22	Bagiella, Emilia
23	Casadevall, Arturo
24	Cordon-Cardo, Carlos
25	Jhang, Jeffrey S
26	Arinsburg, Suzanne A
27	Reich, David L
28	Aberg, Judith A
29	Bouvier, Nicole M

format

journal

genre

article

ristype

JOUR

atitle

Convalescent plasma treatment of severe COVID-19: a propensity score-matched control study

jtitle

Nature medicine

addtitle

Nat Med

date

2020-11

risdate

2020

volume

issue

spage

1708

epage

1713

pages

1708-1713

issn

1078-8956

eissn

1546-170X

abstract

cop

United States

pub

Nature Publishing Group

pmid

32934372

doi

10.1038/s41591-020-1088-9

tpages

orcidid

0	https://orcid.org/0000-0001-8162-0284
1	https://orcid.org/0000-0002-4530-2841
2	https://orcid.org/0000-0003-4121-776X
3	https://orcid.org/0000-0001-6792-7650
4	https://orcid.org/0000-0003-1948-3834
5	https://orcid.org/0000-0002-6013-2684
6	https://orcid.org/0000-0002-3842-6838
7	https://orcid.org/0000-0003-0106-8114
8	https://orcid.org/0000-0003-1103-839X

free_for_read

Suche

Filtern

Bibliotheken

Convalescent plasma treatment of severe COVID-19: a propensity score-matched control study